June 2012 Issue
Articles
Pharma Manufacturing on the Move
Global supply needs are dictating facility locations and CMO selection.
cGMPs and Statistics
FDAs Rick Friedman and Karthik Iyer explain why some manufacturers need to get a better grip on GMP-related statistics.
Biomanufacturing Shows Signs of Maturity, PAT Adoption
Manufacturers are reporting fewer batch failures, adopting PAT and other quality initiatives, and stepping up supply chain quality control.
Biopharma's Flexible Imperative
Business forces, bioterror and pandemic risks demand new approaches to manufacturing.
Manufacturing Strategies for Biosimilars
Regulators have paved the way for low-cost biologics, but its up to manufacturers to select the right technologies and define quality.
Afnan: Biopharm: Thinking Too Linearly?
The idea that the product is the process and the process is the product can either result in sameness, or true control.
Memories of Our Masthead: Julie Cappelletti-Lange
A tribute to our dear friend and colleague, Julie Cappelletti-Lange.
From the Editor: Inspiration and Innovation
The yin is just as important as the yang; sometimes, even more so.
PharmaView: The Future? Let's Get Pumped Up
To survive, Steven Burrill tells Big Pharma, ignore the gravel in the road and embrace the disruption.
Are You Using A Sledgehammer to Monitor Temperature and Humidity?
Facilities often use complex and time-consuming tools to accomplish what should be a simple task.
Sourcing Solutions for Environmental Monitoring: Ask the Right Questions
Accurate answers to the wrong questions pose risks and unnecessarily drive up costs.